Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2020

Year

Théodora Bejan‐Angoulvant, Jean‐Marc Naccache, Agnès Caille, Raphaël Borie, Hilario Nunès, Marion Ferreira, J. Cadranel, Bruno Crestani, Vincent Cottin, S. Marchand‐Adam

Respiratory Medicine and Research

Mycophenolate MofetilClinical TherapeuticImmunologyPharmacotherapyImmunosuppressionImmunotherapyMedicineFirst-line Immunosuppressive Treatment